カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腫瘍用ジェネリック注射剤の世界市場見通し2023年-2029年

◆英語タイトル：Oncology Generic Injectable Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5827）◆商品コード：MMG23JU5827
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oncology Generic Injectable Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの腫瘍用ジェネリック注射剤市場規模と予測を収録しています。・世界の腫瘍用ジェネリック注射剤市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍用ジェネリック注射剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍用ジェネリック注射剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「高分子医薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腫瘍用ジェネリック注射剤のグローバル主要企業は、Teva Pharmaceutical、 Pfizer、 AstraZeneca、 Roche、 Eli Lilly、 GlaxoSmithKline、 Novartis、 Mylan、 Natco Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腫瘍用ジェネリック注射剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腫瘍用ジェネリック注射剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍用ジェネリック注射剤市場：タイプ別市場シェア、2022年
・高分子医薬品、低分子医薬品

世界の腫瘍用ジェネリック注射剤市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍用ジェネリック注射剤市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界の腫瘍用ジェネリック注射剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍用ジェネリック注射剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腫瘍用ジェネリック注射剤のグローバル売上、2018年-2023年
・主要企業における腫瘍用ジェネリック注射剤のグローバル売上シェア、2022年
・主要企業における腫瘍用ジェネリック注射剤のグローバル販売量、2018年-2023年
・主要企業における腫瘍用ジェネリック注射剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Teva Pharmaceutical、 Pfizer、 AstraZeneca、 Roche、 Eli Lilly、 GlaxoSmithKline、 Novartis、 Mylan、 Natco Pharma

*************************************************************

・調査・分析レポートの概要
腫瘍用ジェネリック注射剤市場の定義
市場セグメント
世界の腫瘍用ジェネリック注射剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍用ジェネリック注射剤市場規模
世界の腫瘍用ジェネリック注射剤市場規模：2022年 VS 2029年
世界の腫瘍用ジェネリック注射剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍用ジェネリック注射剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍用ジェネリック注射剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：高分子医薬品、低分子医薬品
腫瘍用ジェネリック注射剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
腫瘍用ジェネリック注射剤の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍用ジェネリック注射剤市場規模 2022年と2029年
地域別腫瘍用ジェネリック注射剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Teva Pharmaceutical、 Pfizer、 AstraZeneca、 Roche、 Eli Lilly、 GlaxoSmithKline、 Novartis、 Mylan、 Natco Pharma
...

Generic drugs are essential in oncology because some anticancer drugs are only available as generics.
This report aims to provide a comprehensive presentation of the global market for Oncology Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Generic Injectable Drugs. This report contains market size and forecasts of Oncology Generic Injectable Drugs in global, including the following market information:
Global Oncology Generic Injectable Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oncology Generic Injectable Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oncology Generic Injectable Drugs companies in 2022 (%)
The global Oncology Generic Injectable Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Large Molecule Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oncology Generic Injectable Drugs include Teva Pharmaceutical, Pfizer, AstraZeneca, Roche, Eli Lilly, GlaxoSmithKline, Novartis, Mylan and Natco Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Generic Injectable Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Generic Injectable Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, by Type, 2022 (%)
Large Molecule Drugs
Small Molecule Drugs
Global Oncology Generic Injectable Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Oncology Generic Injectable Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Generic Injectable Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oncology Generic Injectable Drugs revenues share in global market, 2022 (%)
Key companies Oncology Generic Injectable Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oncology Generic Injectable Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Generic Injectable Drugs, market overview.
Chapter 2: Global Oncology Generic Injectable Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology Generic Injectable Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Generic Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology Generic Injectable Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oncology Generic Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Generic Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Generic Injectable Drugs Overall Market Size
2.1 Global Oncology Generic Injectable Drugs Market Size: 2022 VS 2029
2.2 Global Oncology Generic Injectable Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oncology Generic Injectable Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Oncology Generic Injectable Drugs Players in Global Market
3.2 Top Global Oncology Generic Injectable Drugs Companies Ranked by Revenue
3.3 Global Oncology Generic Injectable Drugs Revenue by Companies
3.4 Global Oncology Generic Injectable Drugs Sales by Companies
3.5 Global Oncology Generic Injectable Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oncology Generic Injectable Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oncology Generic Injectable Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Generic Injectable Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oncology Generic Injectable Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology Generic Injectable Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncology Generic Injectable Drugs Market Size Markets, 2022 & 2029
4.1.2 Large Molecule Drugs
4.1.3 Small Molecule Drugs
4.2 By Type – Global Oncology Generic Injectable Drugs Revenue & Forecasts
4.2.1 By Type – Global Oncology Generic Injectable Drugs Revenue, 2018-2023
4.2.2 By Type – Global Oncology Generic Injectable Drugs Revenue, 2024-2029
4.2.3 By Type – Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Oncology Generic Injectable Drugs Sales & Forecasts
4.3.1 By Type – Global Oncology Generic Injectable Drugs Sales, 2018-2023
4.3.2 By Type – Global Oncology Generic Injectable Drugs Sales, 2024-2029
4.3.3 By Type – Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Oncology Generic Injectable Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncology Generic Injectable Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Oncology Generic Injectable Drugs Revenue & Forecasts
5.2.1 By Application – Global Oncology Generic Injectable Drugs Revenue, 2018-2023
5.2.2 By Application – Global Oncology Generic Injectable Drugs Revenue, 2024-2029
5.2.3 By Application – Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Oncology Generic Injectable Drugs Sales & Forecasts
5.3.1 By Application – Global Oncology Generic Injectable Drugs Sales, 2018-2023
5.3.2 By Application – Global Oncology Generic Injectable Drugs Sales, 2024-2029
5.3.3 By Application – Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Oncology Generic Injectable Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oncology Generic Injectable Drugs Market Size, 2022 & 2029
6.2 By Region – Global Oncology Generic Injectable Drugs Revenue & Forecasts
6.2.1 By Region – Global Oncology Generic Injectable Drugs Revenue, 2018-2023
6.2.2 By Region – Global Oncology Generic Injectable Drugs Revenue, 2024-2029
6.2.3 By Region – Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Oncology Generic Injectable Drugs Sales & Forecasts
6.3.1 By Region – Global Oncology Generic Injectable Drugs Sales, 2018-2023
6.3.2 By Region – Global Oncology Generic Injectable Drugs Sales, 2024-2029
6.3.3 By Region – Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oncology Generic Injectable Drugs Revenue, 2018-2029
6.4.2 By Country – North America Oncology Generic Injectable Drugs Sales, 2018-2029
6.4.3 US Oncology Generic Injectable Drugs Market Size, 2018-2029
6.4.4 Canada Oncology Generic Injectable Drugs Market Size, 2018-2029
6.4.5 Mexico Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oncology Generic Injectable Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Oncology Generic Injectable Drugs Sales, 2018-2029
6.5.3 Germany Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.4 France Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.5 U.K. Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.6 Italy Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.7 Russia Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Oncology Generic Injectable Drugs Market Size, 2018-2029
6.5.9 Benelux Oncology Generic Injectable Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oncology Generic Injectable Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Oncology Generic Injectable Drugs Sales, 2018-2029
6.6.3 China Oncology Generic Injectable Drugs Market Size, 2018-2029
6.6.4 Japan Oncology Generic Injectable Drugs Market Size, 2018-2029
6.6.5 South Korea Oncology Generic Injectable Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Oncology Generic Injectable Drugs Market Size, 2018-2029
6.6.7 India Oncology Generic Injectable Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oncology Generic Injectable Drugs Revenue, 2018-2029
6.7.2 By Country – South America Oncology Generic Injectable Drugs Sales, 2018-2029
6.7.3 Brazil Oncology Generic Injectable Drugs Market Size, 2018-2029
6.7.4 Argentina Oncology Generic Injectable Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oncology Generic Injectable Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oncology Generic Injectable Drugs Sales, 2018-2029
6.8.3 Turkey Oncology Generic Injectable Drugs Market Size, 2018-2029
6.8.4 Israel Oncology Generic Injectable Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Oncology Generic Injectable Drugs Market Size, 2018-2029
6.8.6 UAE Oncology Generic Injectable Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Company Summary
7.1.2 Teva Pharmaceutical Business Overview
7.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Major Product Offerings
7.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Teva Pharmaceutical Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Oncology Generic Injectable Drugs Major Product Offerings
7.2.4 Pfizer Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Oncology Generic Injectable Drugs Major Product Offerings
7.3.4 AstraZeneca Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Oncology Generic Injectable Drugs Major Product Offerings
7.4.4 Roche Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Oncology Generic Injectable Drugs Major Product Offerings
7.5.4 Eli Lilly Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oncology Generic Injectable Drugs Major Product Offerings
7.7.4 Novartis Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Oncology Generic Injectable Drugs Major Product Offerings
7.8.4 Mylan Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Natco Pharma
7.9.1 Natco Pharma Company Summary
7.9.2 Natco Pharma Business Overview
7.9.3 Natco Pharma Oncology Generic Injectable Drugs Major Product Offerings
7.9.4 Natco Pharma Oncology Generic Injectable Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Natco Pharma Key News & Latest Developments
8 Global Oncology Generic Injectable Drugs Production Capacity, Analysis
8.1 Global Oncology Generic Injectable Drugs Production Capacity, 2018-2029
8.2 Oncology Generic Injectable Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology Generic Injectable Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology Generic Injectable Drugs Supply Chain Analysis
10.1 Oncology Generic Injectable Drugs Industry Value Chain
10.2 Oncology Generic Injectable Drugs Upstream Market
10.3 Oncology Generic Injectable Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology Generic Injectable Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oncology Generic Injectable Drugs in Global Market
Table 2. Top Oncology Generic Injectable Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oncology Generic Injectable Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oncology Generic Injectable Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Oncology Generic Injectable Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Oncology Generic Injectable Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oncology Generic Injectable Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Oncology Generic Injectable Drugs Product Type
Table 9. List of Global Tier 1 Oncology Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oncology Generic Injectable Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Oncology Generic Injectable Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oncology Generic Injectable Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Oncology Generic Injectable Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oncology Generic Injectable Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oncology Generic Injectable Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Oncology Generic Injectable Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oncology Generic Injectable Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Oncology Generic Injectable Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oncology Generic Injectable Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oncology Generic Injectable Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oncology Generic Injectable Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oncology Generic Injectable Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oncology Generic Injectable Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Oncology Generic Injectable Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oncology Generic Injectable Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oncology Generic Injectable Drugs Sales, (K Units), 2024-2029
Table 46. Teva Pharmaceutical Company Summary
Table 47. Teva Pharmaceutical Oncology Generic Injectable Drugs Product Offerings
Table 48. Teva Pharmaceutical Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Teva Pharmaceutical Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Oncology Generic Injectable Drugs Product Offerings
Table 52. Pfizer Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Oncology Generic Injectable Drugs Product Offerings
Table 56. AstraZeneca Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Oncology Generic Injectable Drugs Product Offerings
Table 60. Roche Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Eli Lilly Company Summary
Table 63. Eli Lilly Oncology Generic Injectable Drugs Product Offerings
Table 64. Eli Lilly Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Eli Lilly Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Oncology Generic Injectable Drugs Product Offerings
Table 68. GlaxoSmithKline Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Oncology Generic Injectable Drugs Product Offerings
Table 72. Novartis Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. Mylan Company Summary
Table 75. Mylan Oncology Generic Injectable Drugs Product Offerings
Table 76. Mylan Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Mylan Key News & Latest Developments
Table 78. Natco Pharma Company Summary
Table 79. Natco Pharma Oncology Generic Injectable Drugs Product Offerings
Table 80. Natco Pharma Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Natco Pharma Key News & Latest Developments
Table 82. Oncology Generic Injectable Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Oncology Generic Injectable Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Oncology Generic Injectable Drugs Production by Region, 2018-2023 (K Units)
Table 85. Global Oncology Generic Injectable Drugs Production by Region, 2024-2029 (K Units)
Table 86. Oncology Generic Injectable Drugs Market Opportunities & Trends in Global Market
Table 87. Oncology Generic Injectable Drugs Market Drivers in Global Market
Table 88. Oncology Generic Injectable Drugs Market Restraints in Global Market
Table 89. Oncology Generic Injectable Drugs Raw Materials
Table 90. Oncology Generic Injectable Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Oncology Generic Injectable Drugs Downstream
Table 92. Oncology Generic Injectable Drugs Downstream Clients in Global Market
Table 93. Oncology Generic Injectable Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oncology Generic Injectable Drugs Segment by Type in 2022
Figure 2. Oncology Generic Injectable Drugs Segment by Application in 2022
Figure 3. Global Oncology Generic Injectable Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Generic Injectable Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology Generic Injectable Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Oncology Generic Injectable Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oncology Generic Injectable Drugs Revenue in 2022
Figure 9. By Type - Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Oncology Generic Injectable Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Oncology Generic Injectable Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oncology Generic Injectable Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 23. US Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 28. Germany Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 37. China Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oncology Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oncology Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oncology Generic Injectable Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Oncology Generic Injectable Drugs by Region, 2022 VS 2029
Figure 54. Oncology Generic Injectable Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 腫瘍用ジェネリック注射剤の世界市場見通し2023年-2029年(Oncology Generic Injectable Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ドルテグラビル＆ドルテグラビルジェネリック医薬品の世界市場見通し2023年-2029年
  • 腫瘍学（抗がん剤）の世界市場見通し2023年-2029年
  • ジェネリック腫瘍治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆